CLINICAL_TRIALS
research
· 2010-09-09
Clinical Trial Update: A Study for Patients With Relapsing Remitting Multiple Sclerosis [Phase 2, Phase 3]
Summary
A completed Phase 2/Phase 3 clinical trial for Relapsing Remitting Multiple Sclerosis sponsored by Eli Lilly and Company.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Eli Lilly and Company | Conditions: Relapsing Remitting Multiple Sclerosis | Phase 2, Phase 3 | Status: COMPLETED